Brief: Brainsway Says Will Not Invest More Resources To Continue Transcranial Magnetic Stimulation Study In PTSD
06/02/2020 12:18
Feb 6 (Reuters) - Brainsway Ltd BWAY.TA :
* BRAINSWAY REPORTS RESULTS OF INTERIM ANALYSIS OF H7 DEEP
TRANSCRANIAL MAGNETIC STIMULATION STUDY IN POST-TRAUMATIC STRESS
DISORDER
* RESULTS DID NOT DEMONSTRATE SUFFICIENT EFFICACY RELATIVE
TO SHAM
CONTROL TREATMENT IN PTSD PATIENTS
* BASED ON INTERIM ANALYSIS, COMPANY WILL NOT INVEST
ADDITIONAL
RESOURCES IN ORDER TO CONTINUE THIS STUDY
* PERFORMING ADDITIONAL ANALYSIS AND WILL CONSIDER FUTURE
PTSD
STUDIES USING ALTERNATIVE PARAMETERS
Source text for Eikon: ID:nGNXWP1wF
Further company coverage: BWAY.TA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Brainsway
See all newsBrief: Brainsway Presents Positive Data From Largest Real-World Study Of Deep Tms™ In Patients With Comorbid Ptsd And Major Depressive Disorder
Brief: Brainsway Announces Minority-Stake Investment In Hopemark Health
Brief: Brainsway Announces New Minority-Stake Investment In Canadian Provider, Brainstim Health Inc.
Brief: Brainsway Announces Change In ADS-To-Ordinary Share Ratio
Brief: BrainsWay Announces FDA Approval of Neurolief’s Proliv™Rx Neuromodulation System for Major Depressive Disorder (MDD)